254 related articles for article (PubMed ID: 24037882)
1. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
3. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
4. A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.
Monticone S; Bandulik S; Stindl J; Zilbermint M; Dedov I; Mulatero P; Allgaeuer M; Lee CC; Stratakis CA; Williams TA; Tiulpakov A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E114-8. PubMed ID: 25322277
[TBL] [Abstract][Full Text] [Related]
5. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
[TBL] [Abstract][Full Text] [Related]
6. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
7. Role of KCNJ5 in familial and sporadic primary aldosteronism.
Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
9. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
10. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
11. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
Arnesen T; Glomnes N; Strømsøy S; Knappskog S; Heie A; Akslen LA; Grytaas M; Varhaug JE; Gimm O; Brauckhoff M
Langenbecks Arch Surg; 2013 Aug; 398(6):869-74. PubMed ID: 23778974
[TBL] [Abstract][Full Text] [Related]
12. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
[TBL] [Abstract][Full Text] [Related]
14. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
15. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
16. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
[TBL] [Abstract][Full Text] [Related]
18. Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
[TBL] [Abstract][Full Text] [Related]
19. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
20. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
